Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

The mechanism of action of cyclosporin A and FK506

Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo‐Reid, L., Auyeung, G., Antonacci, C. L., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,951

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341

Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells

Lee, S., Lumelsky, N. L., Studer, L., Auerbach, J. M., & McKay, R. D. G. (2000) · Nature Biotechnology · doi:10.1038/76536 · Cited by 1,261

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116

Parkinson's disease

Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920

13 reasons why the brain is susceptible to oxidative stress

Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116

Mitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis

Wong, Y. C., Ysselstein, D., & Krainc, D. (2018) · Nature · doi:10.1038/nature25486 · Cited by 911

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

Calabresi, P., Mechelli, A., Natale, G., Volpicelli‐Daley, L. A., Lazzaro, G. D., & Ghiglieri, V. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05672-9 · Cited by 930

Rhythms of life: circadian disruption and brain disorders across the lifespan

Logan, R. W., & McClung, C. A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0088-y · Cited by 713

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

Mahoney‐Sanchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J. A., & Devedjian, J.-C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101890 · Cited by 572

Oxidative stress and cellular pathologies in Parkinson’s disease

Puspita, L., Chung, S. Y., & Shim, J. (2017) · Molecular Brain · doi:10.1186/s13041-017-0340-9 · Cited by 507

Converging pathways in neurodegeneration, from genetics to mechanisms

Gan, L., Cookson, M. R., Petrucelli, L., & Spada, A. R. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 500

Modeling Alzheimer’s disease with iPSC-derived brain cells

Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471

Determinants of dopaminergic neuron loss in Parkinson's disease

Surmeier, D. J. (2018) · FEBS Journal · doi:10.1111/febs.14607 · Cited by 483

Progress towards therapies for disease modification in Parkinson's disease

Vijiaratnam, N., Simuni, T., Bandmann, O., Morris, H. R., & Foltynie, T. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00061-2 · Cited by 447

Genetics and Pathogenesis of Parkinson's Syndrome

Ye, H., Robak, L. A., Yu, M., Cykowski, M. D., & Shulman, J. M. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-034145 · Cited by 503

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 450

Prodromal Parkinson disease subtypes — key to understanding heterogeneity

Berg, D., Borghammer, P., Fereshtehnejad, S.-M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00486-9 · Cited by 409

New insights into the complex role of mitochondria in Parkinson’s disease

Grünewald, A., Kumar, K. R., & Sue, C. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.003 · Cited by 375

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis

Carballo‐Carbajal, I., Laguna, A., Romero‐Giménez, J., Cuadros, T., Bové, J., Martínez‐Vicente, M., Parent, A., González-Sepúlveda, M., Peñuelas, N., Torra, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08858-y · Cited by 345

Regulation and Function of Mitochondria–Lysosome Membrane Contact Sites in Cellular Homeostasis

Wong, Y. C., Kim, S., Peng, W., & Krainc, D. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.02.004 · Cited by 355

Mitochondria-lysosome contacts regulate mitochondrial Ca 2+ dynamics via lysosomal TRPML1

Peng, W., Wong, Y. C., & Krainc, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003236117 · Cited by 347

Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease

Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A., & Krainc, D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.11.001 · Cited by 323

Impaired dopamine metabolism in Parkinson’s disease pathogenesis

Masato, A., Plotegher, N., Boassa, D., & Bubacco, L. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0332-6 · Cited by 350

Role of dopamine in the pathophysiology of Parkinson’s disease

Zhou, Z., Yi, L., Wang, D. Q., Lim, T. M., & Tan, E. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00378-6 · Cited by 356

Iron in Neurodegeneration – Cause or Consequence?

Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 305

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

Shandilya, S., Kumar, S., Jha, N. K., Kesari, K. K., & Ruokolainen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 310

A single-atom Fe–N 4 catalytic site mimicking bifunctional antioxidative enzymes for oxidative stress cytoprotection

Ma, W., Mao, J., Yang, X., Pan, C., Chen, W., Wang, M., Yu, P., Mao, L., & Li, Y. (2018) · Chemical Communications · doi:10.1039/c8cc08116f · Cited by 283

Mitochondria and Parkinson’s Disease: Clinical, Molecular, and Translational Aspects

Borsche, M., Pereira, S. L., Klein, C., & Grünewald, A. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-201981 · Cited by 288

Ferroptosis and Its Potential Role in Human Diseases

Han, C., Liu, Y., Dai, R., Ismail, N., Su, W., & Li, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00239 · Cited by 283

Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases

Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 274

Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors

Brown, E. E., DeWeerd, A. J., Ildefonso, C. J., Lewin, A. S., & Ash, J. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101201 · Cited by 259

Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?

Muddapu, V. R., Dharshini, S. A. P., Chakravarthy, V. S., & Gromiha, M. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00213 · Cited by 255

SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism

Wang, T., Cao, Y., Zheng, Q., Tu, J., Zhou, W., He, J., Zhong, J., Chen, Y., Wang, J., Cai, R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.008 · Cited by 250

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods

Udayar, V., Chen, Y., Sidransky, E., & Jagasia, R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.004 · Cited by 255

Human iPSC banking: barriers and opportunities

Huang, C., Liu, C.-L., Ting, C.-Y., Chiu, Y.-T., Cheng, Y., Nicholson, M. W., & Hsieh, P. C. H. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0578-x · Cited by 222

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models

Taoufik, E., Kouroupi, G., Zygogianni, O., & Matsas, R. (2018) · Open Biology · doi:10.1098/rsob.180138 · Cited by 213

Impaired dopamine release in Parkinson’s disease

Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J., & Wade-Martins, R. (2023) · Brain · doi:10.1093/brain/awad064 · Cited by 207

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

de Bie, R. M. A., Clarke, C. E., Espay, A. J., Fox, S. H., & Lang, A. E. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30036-3 · Cited by 200

Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease

Kim, S., Wong, Y. C., Gao, F., & Krainc, D. (2021) · Nature Communications · doi:10.1038/s41467-021-22113-3 · Cited by 209

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases

Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 204

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection

Yao, W., Lu, M., Mei, M., Wang, H., Han, Z., Chen, M., Yao, H. P., Song, N., Ding, X. L., Ding, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14788-x · Cited by 198

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Franco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 197

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease

Zeng, X., Geng, W.-S., Jia, J., Chen, L., & Zhang, P.-P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00109 · Cited by 203

Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer

Musgrove, R. E., Helwig, M., Bae, E.-J., Aboutalebi, H., Lee, S., Ulusoy, A., & Monte, D. A. D. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127330 · Cited by 193

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11928-w · Cited by 188

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients

Ysselstein, D., Nguyen, M. N., Young, T. J., Severino, A., Schwake, M., Merchant, K., & Krainc, D. (2019) · Nature Communications · doi:10.1038/s41467-019-13413-w · Cited by 193

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

Graves, S. M., Xie, Z., Stout, K. A., Zampese, E., Burbulla, L. F., Shih, J. C., Kondapalli, J., Patriarchi, T., Tian, L., Brichta, L., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0556-3 · Cited by 192

Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells

Tran, J., Anastacio, H. T. D., & Bardy, C. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0110-8 · Cited by 190

Is Parkinson’s disease a lysosomal disorder?

Klein, A. D., & Mazzulli, J. R. (2018) · Brain · doi:10.1093/brain/awy147 · Cited by 176

SubMito-XGBoost: predicting protein submitochondrial localization by fusing multiple feature information and eXtreme gradient boosting

Yu, B., Qiu, W., Chen, C., Ma, A., Jiang, J., Zhou, H., & Ma, Q. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz734 · Cited by 171

LRRK2 and idiopathic Parkinson’s disease

Rocha, E. M., Keeney, M. T., Maio, R. D., Miranda, B. R. D., & Greenamyre, J. T. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.002 · Cited by 173

CRISPR-based functional genomics for neurological disease

Kampmann, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0373-z · Cited by 163

Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis

Zhang, X., Zhang, Y., Li, R., Zhu, L., Bu-qing, F., & Yan, T. (2020) · Aging · doi:10.18632/aging.103215 · Cited by 160

LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson’s disease

Nguyen, M. N., & Krainc, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717590115 · Cited by 160

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration

Ghiglieri, V., Calabrese, V., & Calabresi, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00295 · Cited by 166

DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy

Imberechts, D., Kinnart, I., Wauters, F., Terbeek, J., Manders, L., Wierda, K. D. B., Eggermont, K., Madeiro, R. F., Sue, C. M., Verfaillie, C. M., et al. (2022) · Brain · doi:10.1093/brain/awac313 · Cited by 168

Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy

Kuo, S.-H., Tasset, I., Cheng, M. M., Diaz, A., Pan, M.-K., Lieberman, O. J., Hutten, S. J., Alcalay, R. N., Kim, S., Ximénez-Embún, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm6393 · Cited by 153

Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation

Percário, S., Barbosa, A. D. S., Varela, E. L. P., Gomes, A. R. Q., Ferreira, M. E. S., Moreira, T. D. N. A., & Dolabela, M. F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2360872 · Cited by 158

Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage

Wei, Y., Miao, Q., Zhang, Q., Mao, S., Li, M., Xu, X., Xia, X., Wei, K., Fan, Y., Zheng, X., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01476-4 · Cited by 153

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease

Vila, M. (2019) · Movement Disorders · doi:10.1002/mds.27776 · Cited by 154

Laser Ablation–Inductively Coupled Plasma–Mass Spectrometry Imaging in Biology

Doble, P., de Vega, R. G., Bishop, D., Hare, D. J., & Clases, D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01219 · Cited by 153

Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease

Nuber, S., Rajsombath, M. M., Minakaki, G., Winkler, J., Müller, C. P., Ericsson, M., Caldarone, B. J., Dettmer, U., & Selkoe, D. J. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.014 · Cited by 153

Lysosomal Dysfunction at the Centre of Parkinson’s Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis

Wallings, R. L., Humble, S. W., Ward, M. E., & Wade-Martins, R. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.10.002 · Cited by 153

A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress

Hanan, M., Simchovitz, A., Yayon, N., Vaknine, S., Cohen‐Fultheim, R., Karmon, M., Madrer, N., Rohrlich, T. M., Maman, M., Bennett, E. R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911942 · Cited by 130

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase

Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., & Wakamatsu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084176 · Cited by 144

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine

Iarkov, A., Barreto, G. E., Grizzell, J. A., & Echeverrı́a, V. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00004 · Cited by 146

Emerging roles of mitochondria in synaptic transmission and neurodegeneration

Lee, A., Hirabayashi, Y., Kwon, S., Lewis, T. L., & Polleux, F. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.009 · Cited by 131

The Close Encounter Between Alpha-Synuclein and Mitochondria

Vicario, M., Cieri, D., Brini, M., & Calí, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00388 · Cited by 135

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products

Chakrabarti, S., & Bisaglia, M. (2023) · Antioxidants · doi:10.3390/antiox12040955 · Cited by 145

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 143

Current Trends in Neurodegeneration: Cross Talks between Oxidative Stress, Cell Death, and Inflammation

Behl, T., Makkar, R., Sehgal, A., Singh, S., Sharma, N., Zengin, G., BUNGAU, S. G., Andronie-Cioară, F. L., Munteanu, M. A., Brisc, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147432 · Cited by 134

Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration

Zhang, S., Wang, R., & Wang, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00454 · Cited by 133

Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases

Kampmann, M. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00806-0 · Cited by 142

Melanin/polydopamine-based nanomaterials for biomedical applications

Qi, C., Fu, L., Xu, H., Wang, T., Lin, J., & Huang, P. (2019) · Science China Chemistry · doi:10.1007/s11426-018-9392-6 · Cited by 132

Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease

Mitroshina, Е. V., Saviuk, M. O., Ponimaskin, E. G., & Vedunova, M. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703084 · Cited by 136

Cholinergic modulation of striatal microcircuits

Abudukeyoumu, N., Hernández-Flores, T., Garcia-Munoz, M., & Arbuthnott, G. W. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13949 · Cited by 144

Erratum To: A Parkinson’s disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress

Hanan, M., Simchovitz, A., Yayon, N., Vaknine, S., Cohen‐Fultheim, R., Karmon, M., Madrer, N., Rohrlich, T. M., Maman, M., Bennett, E. R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013551 · Cited by 128

Three-dimensional nanostructured graphene: Synthesis and energy, environmental and biomedical applications

Olszowska, K., Pang, J., Wrobel, P. S., Zhao, L., Ta, H. Q., Liu, Z., Trzebicka, B., Bachmatiuk, A., & Rümmeli, M. H. (2017) · Synthetic Metals · doi:10.1016/j.synthmet.2017.10.014 · Cited by 129

Targeting mitophagy in Parkinson's disease

Clark, E. H., de la Torre, A. V., Hoshikawa, T., & Briston, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014294 · Cited by 132

Sphingolipids in the Pathogenesis of Parkinson’s Disease and Parkinsonism

Lin, G., Wang, L., Marcogliese, P. C., & Bellen, H. J. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.11.003 · Cited by 132

GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia

Chong, M., Mohammadi‐Shemirani, P., Perrot, N., Nelson, W., Morton, R. W., Narula, S., Lali, R., Khan, I. I., Khan, M. D., Judge, C. S., et al. (2022) · eLife · doi:10.7554/elife.70382 · Cited by 130

The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD)

Zhou, Z., Xie, S. P., Saw, W. T., Ho, P., Wang, H.-Y., Zhou, L., Zhao, Y., & Tan, E. K. (2019) · Cells · doi:10.3390/cells8080911 · Cited by 126

Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix

Brand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123

A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides

Paul, K. C., Krolewski, R. C., Moreno, E. L., Blank, J., Holton, K. M., Ahfeldt, T., Furlong, M., Yu, Y., Cockburn, M., Thompson, L. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38215-z · Cited by 132

The role of glucocerebrosidase in Parkinson disease pathogenesis

Gegg, M. E., & Schapira, A. H. V. (2018) · FEBS Journal · doi:10.1111/febs.14393 · Cited by 126

Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Wong, Y. C., Luk, K. C., Purtell, K., Burke, S., Stoessl, A. J., Trudeau, L., Yue, Z., Krainc, D., Oertel, W. H., Obeso, J. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27823 · Cited by 126

iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates

Laperle, A., Sances, S., Yucer, N., Dardov, V. J., Garcia, V. J., Ho, R., Fulton, A., Jones, M. R., Roxas, K., Avalos, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0739-1 · Cited by 124

Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration

Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 118

Autophagy and Parkinson’s Disease

Lu, J., Wu, M., & Yue, Z. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-4272-5_2 · Cited by 131

α-Synuclein in Parkinson’s disease: causal or bystander?

Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T. H., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 122

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease

Gcwensa, N. Z., Russell, D. L., Cowell, R. M., & Volpicelli-Daley, L. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.626128 · Cited by 110

Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite

Heremans, I. P., Caligiore, F., Gerin, I., Bury, M., Lutz, M., Graff, J., Stroobant, V., Vertommen, D., Teleman, A. A., SCHAFTINGEN, E. V., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111338119 · Cited by 114

Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition

Sanyal, A., DeAndrade, M. P., Novis, H. S., Lin, S. C., Chang, J., Lengacher, N. A., Tomlinson, J. J., Tansey, M. G., & LaVoie, M. J. (2020) · Movement Disorders · doi:10.1002/mds.27994 · Cited by 111

Tau in the Pathophysiology of Parkinson’s Disease

Pan, L., Meng, L., He, M., & Zhang, Z. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01776-5 · Cited by 110

Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma

Sun, M., Wang, C., Lv, M., Fan, Z., & Du, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00697 · Cited by 108

Cellular and molecular pathophysiology in the progression of Parkinson’s disease

Zaman, V., Shields, D. C., Shams, R., Drasites, K. P., Matzelle, D. D., Haque, A., & Banik, N. L. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00689-5 · Cited by 119

Mitophagy and reactive oxygen species interplay in Parkinson’s disease

Xiao, B., Kuruvilla, J., & Tan, E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00402-y · Cited by 117

Apoptosis and its Role in Parkinson’s Disease

Erekat, N. S. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch4 · Cited by 109

A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease

Burbulla, L. F., Jeon, S., Zheng, J., Song, P., Silverman, R. B., & Krainc, D. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6870 · Cited by 109

The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols

Aryal, S., Skinner, T., Bridges, B., & Weber, J. T. (2020) · Molecules · doi:10.3390/molecules25194382 · Cited by 113

Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications

Xu, D., Li, Y., Yin, S., & Huang, F. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00926b · Cited by 109

Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson's disease

Han, X., Zhao, S., Song, H., Xu, T., Fang, Q., Hu, G., & Sun, L. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101911 · Cited by 107

Dopamine oxidation mediates a human-specific cascade of mitochondrial and lysosomal dysfunction in Parkinson's disease.

Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · Cited by 3

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease

Minakaki, G., Krainc, D., & Burbulla, L. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580634 · Cited by 87

Dopamine Oxidation and Parkinson’s Disease

Barrett, C. W., Bucher, M. L., & Hastings, T. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00116 · Cited by 1

Toxic effects of the oxidized products of the neurotransmitter dopamine on mitochondria and their implications in Parkinson's disease

Arduini, I. (2008) · Padua Research Archive (University of Padova)